Intact nuclear membrane in necrotic keratinocytes of Stevens-Johnson syndrome distinguishes complement-mediated target cell lysis in ADCC from cytotoxic T-lymphocyte-mediated cytolysis

References

• Ackerman A B, Penneys N S, Clark W H. Erythema multiforme exudativum: a distinctive pathological process. Br J Dermatol 1971; 84: 554–66
   Google Scholar
• Orfanos C E, Schaumburg-Lever G, Lever W F. Dermal and epidermal types of erythema multiforme. Arch Dermatol 1974; 109: 682–8
   PubMedGoogle Scholar
• Huff J C. Immunologic mechanisms of erythema multiforme. Immune mechanisms in cutaneous disease, D A Norris. Marcel Dekker, New York 1989; 387–402
   Google Scholar
• Tonnesen M G, Harrist T J, Wintroub B U, et al. Erythema multiforme microvascular damage and infiltration of lymphocytes and basophils. J Invest Dermatol 1983; 80: 282–6
   PubMed Web of Science ®Google Scholar
• Margolis R J, Tonnesen M G, Harrist T J, et al. Lymphocyte subsets and Langerhans cells, indeterminate cells in erythema multiforme. J Invest Dermatol 1983; 81: 403–6
   PubMed Web of Science ®Google Scholar
• Zaim M T, Giornp R C, Golitz L E, et al. An immunopathologic study of herpes-associated erythema multiforme. J Cutan Pathol 1987; 14: 257–62
   Google Scholar
• Mayer M M. The cytolytic attack mechanism of complement. Monogr Allergy 1977; 12: 1–12
   Google Scholar
• Russell J H, Masakowski V R, Dobos C B. Mechanisms of immune lysis. I. Physiological distinction between target cell death mediated by cytolytic T lymphocytes and antibody plus complement. J Immunol 1980; 124: 1100–5
   PubMedGoogle Scholar
• Duke R C, Chervenak R, Cohen J J. Endogenous endonuclease induced DNA fragmentation: an early event in cell mediated cytolysis. Proc Natl Acad Sci USA 1983; 80: 6361–5
   PubMed Web of Science ®Google Scholar
• Tschopp J, Jongeneel C V. Cytotoxic T lymphocyte mediated cytolysis. Biochemistry 1988; 27: 2641–6
   PubMed Web of Science ®Google Scholar
• Dourmashkin R R, Deteix P, Simone C B, et al. Electron microscopic demonstration of lesions in target cell membranes associated with antibody-dependent cellular cytotoxicity. Clin Exp Immunol 1980; 42: 554–60
   PubMed Web of Science ®Google Scholar
• Podack E R, Dennert G. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 1983; 302: 442–5
   Google Scholar
• Norris D A, Lee L A. Antibody dependent cellular cytotoxicity and skin disease. J Invest Dermatol 1985; 165s–175s
   Google Scholar
• Heng M CY. Efficacy of cyclophosphamide in toxic epidermal necrolysis. J Am Acad Dermatol 1991; 25: 778–86
   PubMed Web of Science ®Google Scholar
• Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol 1979; 100: 69–86
   PubMed Web of Science ®Google Scholar
• Kazmierowski J A, Wuepper K D. Erythema multiforme: immune complex vasculitis of the superficial microvas-culature. J Invest Dermatol 1978; 71: 366–9
   Google Scholar
• Buskell L L, Mackel S E, Jordon R E. Erythema multiforme: direct immunofluorescence studies and detection of circulating immune complexes. J Invest Dermatol 1980; 74: 372–4
   Google Scholar
• Zubler R H, Lange G, Lambert P H, et al. Detection of immune complexes in unheated sera by a modified 1251-C1q binding test. Effect of heating on the binding of C1q by immune complexes and application of the test to systemic lupus erythematosus. J Immunol 1976; 116: 232–5
   PubMed Web of Science ®Google Scholar
• Mackel S E, Tappeiner G, Brumfield H, et al. Circulating immune complexes in cutaneous vasculitis. Detection with C1q and monoclonal rheumatoid factor. J Clin Invest 1979; 64: 1652–60
   Google Scholar
• Neville M E. Human killer cells and natural killer cells: distinct subpopulations of Fc receptor bearing lymphocytes. J Immunol 1980; 125: 2604–9
   Google Scholar
• Neville M E, Lischner W. Activaiton of Fc receptor bearing lymphocytes by immune complexes. I. Stimulation of lymphokine production by non-adherent human peripheral blood lymphocytes. J Immunol 1982; 128: 1063–9
   Google Scholar
• Foerster D W, Scott L V. Isolation of herpes simplex virus from a patient with erythema multiforme exudativum (Stevens Johnsom syndrome). N Engl J Med 1958; 259: 473
   PubMed Web of Science ®Google Scholar
• Shelley W B. Herpes simplex virus as a cause of erythema multiforme. JAMA 1967; 201: 153–6
   Web of Science ®Google Scholar
• Kazmierowski J A, Piezner D S, Wuepper K D. Herpes simplex antigen in immune complexes of patients with erythema multiforme: presence following recurrent herpes simplex infection. JAMA 1982; 247: 2547–50
   Google Scholar
• Orton P W, Huff J C, Tonnesen M G, et al. Detection of a herpes simplex viral antigen in skin lesions of erythema multiforme. Ann Intern Med 1984; 101: 48–50
   PubMedGoogle Scholar
• Lyell A, Dick H M, Gordan A M, et al. Mycoplasmas and erythema multiforme. Lancet 1967; 2: 1116–18
   Google Scholar
• Delafuente J C. Drug-induced erythema multiforme. A possible immunopathologic pathogenesis. Drug Intell Clin Pharm 1985; 19: 114–17
   PubMedGoogle Scholar
• Cines D B, Lyss A P, Bina M, et al. Fc and C3 receptors induced by herpes simplex virus on cultured human endothelial cells. J Invest Dermatol 1982; 69: 123–8
   Google Scholar
• Perlmann P, Perlmann H, Lachmann P. Lymphocyte- associated complement: a role of C8 in certain cell-mediated lytic reactions. Scand J Immunol 1974; 3: 77–84
   Google Scholar
• Fuson E W, Lamon E W. IgM-induced cell-mediated cytotoxicity with antibody and effector cells of human origin. J Immunol 1977; 118: 1907–9
   Google Scholar
• Sundamo J S, Muller-Eberhard H J. Neoantigen of the complement membrane attack complex on cytotoxic human peripheral blood lymphocytes. J Immunol 1979; 122: 2371–8
   Google Scholar
• Renfro L, Grant-Kels J M, Feder H M, Jr, et al. Controversy: are systemic steroids indicated in the treatment of erythema multiforme. Pediatr Dermatol 1989; 6: 43–50
   PubMed Web of Science ®Google Scholar
• Agostas W N, Reeves N, Shanks E D, et al. Erythema multiforme bullosum (Stevens-Johnson syndrome). N Engl J Med 1952; 246: 217–19
   Google Scholar
• Vander Meer R, Wilson D F, Bulthuis J E. Therapeutic effect of ACTh in Stevens Johnson syndrome (erythema multiforme). N Engl J Med 1953; 248: 806–8
   Google Scholar
• Caldwell W GD. Stevens Johnson syndrome treated with ACTH. Lancet 1953; 1: 1127–8
   Google Scholar
• Weeks V T, Lehmann W. Erythema multiforme exudativum treated with cortisone in adrenocorticotrophic hormone. J Pediatr 1954; 44: 508–15
   Google Scholar
• North R J, Havell E A. Glucocorticoid-mediated inhibition of endotoxin-induced intratumor tumor necrosis factor production and tumor hemorrhagic necrosis and regression. J Exp Med 1989; 170: 703–10
   Google Scholar
• Tsujimoto M, Adachi H. Effects of steroid hormones on the cytotoxic effects of tumor necrosis factor. J Biochem (Tokyo) 1988; 103: 393–5
   Google Scholar
• Wakefield P E, James W D, Samlaska C P, et al. Tumor necrosis factor. J Am Acad Dermatol 1991; 24: 675–85
   Google Scholar
• Griffiths C E, Voorhees J J, Nickoloff B J. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 1989; 57: 1953–8
   Google Scholar
• Rasmussen J E. Erythema multiforme in children: response to treatment with systemic corticosteroids. Br J Dermatol 1976; 95: 181–6
   Google Scholar
• Ginsburg C M. Stevens Johnson syndrome in children. Pediatr Infect Dis J 1982; 1: 155–8
   Web of Science ®Google Scholar
• Ting H C, Adams B A. Erythema multiforme—response to corticosteroids. Dermatologica 1984; 169: 175–7
   Google Scholar
• Ting H C, Adams B A. Stevens Johnson syndrome. A review of 34 cases. Int J Dermatol 1985; 24: 587–91
   Google Scholar